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ABSTRACT 
Foot-and-mouth disease virus (FMDV) is a significant economically and distributed globally pathogen of 
Artiodactyla. Current vaccines are chemically inactivated whole virus particles that require large-scale 
virus growth in strict bio-containment with the associated risks of accidental release or incomplete 
inactivation. Non-infectious empty capsids are structural mimics of authentic particles with no associated 
risk and constitute an alternate vaccine candidate. Capsids self-assemble from the processed virus 
structural proteins, VP0, VP3 and VP1, which are released from the structural protein precursor P1-2A by 
the action of the virus-encoded 3C protease. To date recombinant empty capsid assembly has been limited 
by poor expression levels, restricting the development of empty capsids as a viable vaccine. Here 
expression of the FMDV structural protein precursor P1-2A in insect cells is shown to be efficient but 
linkage of the cognate 3C protease to the C-terminus reduces expression significantly. Inactivation of the 
3C enzyme in a P1-2A-3C cassette allows expression and intermediate levels of 3C activity resulted in 
efficient processing of the P1-2A precursor into the structural proteins which assembled into empty 
capsids. Expression was independent of the insect host cell background and leads to capsids that are 
recognised as authentic by a range of anti-FMDV bovine sera suggesting their feasibility as an alternate 
vaccine.  
 
 
 
 
Keywords: Foot-and-mouth disease virus; recombinant baculovirus; empty capsids; protein processing; 
frameshift; 3C protease; vaccine. 
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1. INTRODUCTION 
Foot-and-mouth disease virus (FMDV) is the prototypic aphthovirus within the family Picornaviridae 
(reviewed by (Grubman and Baxt, 2004)). Economic losses from foot-and-mouth disease outbreaks are 
among the highest of all livestock diseases and widespread vaccination is the method of choice for disease 
control (Rodriguez and Grubman, 2009). The current vaccine is a killed whole virus vaccine whose 
limitations have been widely discussed; growth of the live virus prior to inactivation is not without risk, 
the appropriate serotype for each outbreak is required, some field strains grow poorly before adaptation 
and immunogenicity can be lost upon storage (Rodriguez and Grubman, 2009). To address these issues 
alternate vaccines have been sought, among them the use of empty capsids which are structural and 
immunogenic mimics of virus particles but lack the potential for causing disease outbreak (Rowlands et 
al., 1975; Rweyemamu et al., 1979).  
As for all picornaviruses, the icosahedral FMDV capsid is assembled from mature proteins derived from a 
structural precursor, P1-2A, following cleavage in trans by the 3C protease (reviewed by (Belsham, 
2005)). The 3C protease is one of many non-structural proteins synthesised in the infected cell but 
expression of P1-2A and 3C in the absence of any other FMDV encoded protein in recombinant systems 
is sufficient to afford authentic precursor cleavage (Lewis et al., 1991; Roosien et al., 1990). Accordingly 
there have been a number of reports of the assembly of recombinant FMDV empty capsids following the 
use of expression systems such as vaccinia virus (Abrams et al., 1995), adenovirus (Mason et al., 2003), 
E.coli (Cao et al., 2010; Lewis et al., 1991), transgenic plants (Pan et al., 2008) and baculovirus (Li et al., 
2008; Oem et al., 2007; Roosien et al., 1990). In some cases, sufficient empty capsid material has been 
prepared to immunise cattle and protection against homologous challenge was demonstrated (Li et al., 
2008; Li et al., 2011) but in the main the configuration of the P1and 3C coding sequences used to achieve 
empty capsid expression and the efficiency of capsid assembly has been highly variable, particularly in 
insect cells. For example, using the successful expression of swine vesicular disease empty capsids as an 
exemplar (Ko et al., 2005), usage of a dual promoter vector in which the P1 and 3C coding sequences of 
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an O serotype of FMDV were under the control of the baculovirus polyhedrin and p10 promoters 
respectively, resulted in incomplete precursor cleavage and predominantly pentameric assemblies rather 
than complete capsids (Oem et al., 2007). Similarly, a dual expression strategy of an Asia 1 serotype of 
FMDV led to incomplete cleavage of the P1-2A precursor (Cao et al., 2009). More recently, forsaking the 
use of 3C to generate the mature capsid proteins, VP0 and VP3-2A-VP1 from an O serotype of FMDV 
were co-expressed relying on self-cleavage at the 2A site (Donnelly et al., 2001) to generate the requisite 
structural proteins for assembly, which resulted in partial success (Cao et al., 2010). In a further example, 
a Bombyx (silk worm) baculovirus system encoding a P1-2A-3C sequence of an FMDV Asia 1 isolate 
was used as a single transcription unit driven by the polyhedrin promoter and the empty capsid material 
harvested from the haemolymph of the infected silk worms was immunogenic in cattle and led to levels of 
neutralising antibody associated with protection (Li et al., 2008; Li et al., 2011). Despite these successes, 
variation associated with both the FMDV serotype and the host cell background used mean that a uniform 
genetic design capable of producing empty capsids for any serotype has yet to be reported. Recently, the 
yield of empty capsids from insect cells for another picornavirus, human enterovirus 71, was improved by 
use of a dual vector in which a less active promoter, the CMV early promoter, was used for transcription 
of the 3C coding unit whilst the strong polyhedrin promoter directed expression of the P1 structural 
precursor (Chung et al., 2010). However, yield improvement was restricted to Sf9 cells as infection of 
T.ni cells, an alternative insect cell line that generally gives higher expression levels (Davis et al., 1993), 
resulted in poor capsid expression plausibly as a result of low levels of promoter-specific transcription 
factors present in T.ni cells. Picornaviruses traditionally exhibit a strong “host cell shutoff” phenotype 
which is partly the result of 3C protease cleavage of host cell proteins in addition to its action on the virus 
structural precursor P1 (Li et al., 2001; Strong and Belsham, 2004). As a result, picornavirus replication 
cycles are typically rapid and exhibit extensive cytopathic effect (e.g. (Rodriguez Pulido et al., 2007)). It 
follows that if cleavage of host cell proteins by FMDV 3C protease was to occur in a recombinant empty 
capsid expression system it would curtail the expression period and limit the yield of capsids observed. 
Thus, variable levels of 3C expression could account for the variation in the levels of FMDV empty 
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capsids reported to date and purposeful moderation of 3C activity might enhance the yield of capsid 
observed, allowing a more thorough exploration of their virtues as vaccine candidates.  Here a new 
genetic design is described for the expression of empty FMDV capsids in insect cells following infection 
by recombinant baculoviruses expressing P1-2A-3C with a number of modifications to reduce 3C 
activity.  
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2. MATERIALS AND METHODS 
2.1 Cell culture and virus growth 
Sf9, T.ni and T.nao38 cells were cultured in BioWhittaker ®Insect-Xpress (Lonza, Basel, Switzerland)  
supplemented with 2% FCS, 100 units/ml penicillin, 100 µg/ml streptomycin and 2.5 μg/ml amphotericin 
B. Cells were grown at 28°C as monolayers or in suspension with agitation at 100 rpm. Baculoviruses 
were generally amplified in monolayer cultures but large scale infections for capsid isolation were done in 
suspension. Virus stocks were titreed using plaque assay on Sf9 monolayers. 
2.2 Sequences and cloning 
The sequence for FMDV A22 Iraq (AY593764.1) was that deposited in the database. DNA was 
synthesised de novo (Lifetechnologies, Carlsbad, USA). The transfer vector used for all expressions was 
based on pOPINE (Berrow et al., 2007), itself a derivative of pTriEx1.1 (EMD Biosciences, Billerica, 
USA) and a fragment encoding P1-2A-3C of FMDV serotype A22 was cloned downstream of the p10 
promoter by use of In-Fusion technology (Clontech, Mountain View, USA). Mutations within this 
cassette were introduced by the swapping of appropriate fragments via unique restriction sites introduced 
during gene synthesis. Recombination between pOPINE vectors and AcMNPV bacmid KO1629 in insect 
cells was as described (Zhao et al., 2003). Routine DNA procedures in vitro made use of standard 
protocols or, when kits were used, those recommended by the vendor. All vectors were confirmed by 
DNA sequencing prior to use for expression. 
2.3 Electrophoresis and western blotting  
Protein samples were separated on pre-cast 10% Tris-HCl SDS-polyacrylamide gels (BioRad, Berkeley, 
USA) and transferred to Immobilon-P membranes (Millipore, Billerica, USA) using a semi-dry blotter. 
For 10-well gels each sample loaded represented 5 x 10
4
 cells. Following transfer, filters were blocked for 
one hour at room temperature using PBS containing 0.1% v/v Tween-20 (PBS-T), 5% w/v milk powder. 
Primary antibodies were used at 1 μg/ml or at a dilution of 1:1000 in PBS-T, 5% w/v milk powder. 
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Following several washes with PBS-T, the membranes were incubated for 1 hour with the appropriate 
HRP-conjugates and the bound antibodies detected by BM chemiluminescence (Roche, Basel, 
Switzerland).  
2.4 Purification of empty capsids 
Infected cultures (typically ~10
9
 cells) were harvested at 3 days pi and lysed by resuspension in 1/20th of 
the original volume of 1% Triton X-100 in PBS and held at 4
O
C for 30 minutes with occasional agitation. 
Unbroken cells and nuclei were removed by centrifugation (4500 rpm, 15 min) and the clarified lysate 
layered onto a 30% sucrose (w/v in PBS) cushion. After centrifugation at 100,000 g for 100 minutes the 
supernatant was discarded and the pellet resuspended in 1/10 tube volume of PBS containing 3500 units 
of benzonase. After 30 min at room temperature, the solution was clarified and applied to a preformed 
discontinuous 30% to 60% sucrose (w/v in PBS) gradient made up by seven increments of 5%. The 
gradient was developed by centrifugation at 100,000 g for 16 hrs and fractionated from the top. 
2.5 Assessing capsid antigenicity 
Assays to measure the reactivity of recombinant empty capsids with a range of FMDV serotype specific 
polyclonal antisera were performed in a competitive ELISA format as described (Li et al., 2012). Data 
were expressed as percentage inhibition scores compared to an OIE standard antigen preparation. 
Statistical significance was assessed by one-way analysis of variance (ANOVA).  
2.6 Electron microscopy 
Samples were allowed to adhere to carbon coated formvar grids for 5 min at room temperature followed 
by a brief water wash (1 min) before staining with 1% uranyl acetate for 1 min. Excess stain was removed 
by blotting and the grids examined on a Philips CM20 (Philips Electronics, Amsterdam, Netherlands) 
operating at 80kV.  
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3. RESULTS  
Preliminary experiments with constructs (Figure 1A) encoding the previously defined minimum proteins 
for FMDV capsid protein expression and cleavage (Lewis et al., 1991; Roosien et al., 1990) based on a 
synthetic sequence of FMDV A22 Iraq revealed that expression of P1-2A led to the abundant synthesis of 
FMDV-related antigen of the expected molecular weight (~90kDa) as well as some non-specific 
degradation products, whilst fusion of 3C in phase with the C terminus of P1-2A effectively abolished 
expression (Figure 1B). When the same expression cassette included a site-directed change of the 3C 
active site cysteine 163 to alanine (Sweeney et al., 2007), expression of a protein of the molecular weight 
of P1-2A fused to 3C (a minor product) in addition to P1-2A (the predominant product) (~110 kDa and 
~90 kDa respectively) was observed (Figure 1B). Thus, 3C activity and not a cis acting sequence acts to 
restrict P1-2A expression. As a lower 3C activity might be compatible with an enzyme level sufficient to 
allow P1-2A expression and subsequent cleavage, expression cassettes were designed to reduce 3C 
activity. Two approaches were used: site-directed mutagenesis of 3C, based on the three-dimensional 
structure of the enzyme, that had previously been shown to reduce enzyme activity in vitro (Sweeney et 
al., 2007), and the introduction of the HIV-1 ribosomal frameshift site, which has been shown to function 
in insect cells (Adamson et al., 2003), between the P1-2A and 3C coding sequences (Figure 1A). 
Expression screening revealed that individual changes at 3C residue 142 led to the detection of a band at 
~26 kDa consistent with the expected molecular weight of the mature VP1 product following 3C cleavage 
of the P1-2A precursor protein. A combination of both the frameshift and the 3C Cys142Thr mutation 
was the most productive approach leading to almost complete processing of P1-2A as monitored by the 
appearance of VP1 (Figure 1B). The serum used for the western blot detection of FMDV proteins was 
polyvalent but reactivity was largely directed to epitopes in VP1. However, some reactivity with 
intermediates (e.g. VP3-VP1) in the cleavage reaction is apparent. In addition, the resulting optimised 
vector allows exchange of the FMDV P1-2A coding region via unique restriction sites (Figure 2A) 
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permitting any FMDV capsid serotype to be juxtaposed to the moderated 3C translation product (Figure 
2B). 
A feature of the expression designs described here, which differs from most previous examples, is that 
only one transcription unit is present, in this case driven by the AcMNPV p10 promoter and control of 3C 
expression is achieved wholly at the level of translation. Previous examples of high level picornavirus 
expression with moderated 3C activity have used different promoters but exhibited strong host cell 
variability (Chung et al., 2010). To assess expression in a variety of insect cells, a high titre baculovirus 
stock of the optimal A22 P1-2A-FS-3C-C142T construct was used to infect Spodoptera frugiperda (Sf9) 
and two Trichoplusia ni (T.ni and T.nao38) cell lines and a time course of FMDV antigen expression was 
conducted. Sf9 cells are widely used for recombinant baculovirus work but T.ni lines have been shown to 
give higher expression levels in some cases (Hashimoto et al., 2010; Hashimoto et al., 2012; Maruniak et 
al., 1994). FMDV VP1 antigen was apparent at 2 days post infection in all lines tested with peak levels 
occurring at 3 and 4 days post infection (Figure 3A) typical of baculovirus very late promoter driven 
expression (Loureiro et al., 2011; Pengelley et al., 2006). Little unprocessed P1-2A was observed 
suggesting that expression and cleavage are tightly coupled, as expected of a polyprotein and protease 
translated from a single mRNA. Both T.ni cell lines expressed higher levels of FMDV antigen when 
compared to Sf9 cells on a volume equivalent basis with the rank order, based on VP1 band intensity, 
being T.nao38>T.ni>>Sf9. Differences in signal intensity in the different cell lines did not relate to levels 
of baculovirus infection as western blotting for a baculovirus encoded protein, the major structural 
glycoprotein gp64, showed similar levels of infection (Figure 3B). In addition, one commercial cell line, 
VE cells, in which a viral ankaryn repeat protein from Campoletis sonorensis ichnovirus has been 
integrated into the Sf9 genome to reduce levels of AcMPNV-induced apoptosis (Fath-Goodin et al., 2009) 
was tested but they offered no advantage when compared to unmodified Sf9 cells (unpublished 
observations). Based on the results obtained analogous constructs for the seven FMDV serotypes should 
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express similarly although further engineering may be required to optimise the expression level of any 
one sequence. 
Cleavage of the FMDV P1-2A precursor protein into mature structural proteins can lead to empty capsid 
assembly (Cao et al., 2009; Cao et al., 2010) although incomplete assembly has also been observed (Oem 
et al., 2007). To test for the production of empty capsids in the system described here, extracts of infected 
insect cells harvested at 3 days post infection were clarified by low speed centrifugation and the 
particulate material present in the supernatant was collected by sedimentation through a 30% sucrose 
cushion and subsequently on a sucrose velocity gradient. Fractions from the middle of the gradient (~40% 
sucrose), typically the sedimentation position of intact empty capsids, were positive for VP1 by western 
blot (Figure 4A). Electron microscopy of the same fractions revealed uniform structures typical of 
picornavirus capsids with stain penetration consistent with empty capsid assembly (Figure 4B).  
To ensure the empty capsids observed were authentic structural mimics of FMDV particles they were 
compared with inactivated FMDV grown in BHK21 cells in a sandwich ELISA format using a number of 
interrogating sera (Li et al., 2012). Of 38 different bovine sera, representing seroconversion to infection or 
vaccination with serotype A virus or vaccine, no significant differences (P<0.001) were observed between 
the performance of the recombinant empty capsids and the more established virus antigen source (Figure 
5). These data suggest that the recombinant empty capsids are faithful mimics of authentic virus, at least 
to the level probed by the antibodies used here. Purified empty FMDV capsids expressed in insect cells 
raised neutralising antibodies in guinea-pigs as measured by two OIE prescribed tests for the presence of 
specific antibodies: the virus neutralisation test (VNT) and the liquid phase blocking ELISA (LPBE) with 
the levels of neutralising antibody consistent with protection in animal models (not shown). 
4. DISCUSSION  
A new genetic design has been investigated as a robust platform technology for the efficient production of 
empty FMDV capsids. Previous approaches to recombinant picornavirus particle synthesis in insect cells 
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have included the expression of the complete picornaviruses genomes (Brautigam et al., 1993; Rosen et 
al., 1993) as well as co-expression of only the structural precursor protein P1 (or P1-2A) and protease, but 
the levels of capsid obtained have been variable (Cao et al., 2010; Ko et al., 2005; Li et al., 2008; Li et al., 
2011; Oem et al., 2007; Roosien et al., 1990). A systematic analysis of the causes of the observed 
variation is not available although the lower pH of insect cell media is not a major factor (Medina et al., 
1995). FMDV 3C enzymes have a reported wide range of cellular targets in addition to the virus P1-2A 
structural protein precursor suggesting that host protein cleavage could occur in insect cells to effectively 
curtail expression over the 2-4 days of a baculovirus infection. A reduced level of 3C was anticipated to 
be sufficient to enable P1-2A cleavage but be insufficient to cause general toxicity. Bicistronic vectors, in 
which the 3C coding sequence is transcribed from a less active promoter have been encouraging but were 
dependent on host cell factors (Chung et al., 2010) suggesting that other methods of translational control, 
for example through the use of IRES or frameshift elements (Probst, 2002; Royall et al., 2004) might be 
usefully applied. Combining structure-based amino acid substitutions in a flap that folds over the 
substrate binding pocket of 3C (Sweeney et al., 2007; Zunszain et al., 2010), with the introduction of a 
frameshift signal between the P1-2A and 3C coding regions designed to lower the level of 3C translated 
rescued capsid protein expression. The well characterised HIV-1 frameshift (Dinman, 2012) has a 
measured -1 shift rate of about ~1:20 in mammalian cells suggesting 3C levels would be reduced to 5% of 
those associated with the in-frame P1-2A-3C cassette. However, as the rate of frameshift in insect cells 
has not been measured directly, the actual amount of 3C expression remains to be determined. It is 
noteworthy that the -ribbon modified here was also observed in other recent 3C enzyme structures (Cui 
et al., 2011; Lu et al., 2011; Norder et al., 2011) indicating that similar strategies to reduction in 3C 
activity may be usefully applied to the synthesis of other picornavirus empty capsids. Similarly, 
frameshifting rates may be altered through modification of the “slippery sequence” on which the 
ribosome shifts register (Wilson et al., 1988), suggesting further optimisation may be feasible. The 
expression strategy shown here for the FMDV A serotype has also been successful for O and SAT2 
serotypes in preliminary experiments (not shown) implying that the technology may be generally 
Page 12 of 26
Ac
ce
pte
d M
an
us
cri
pt
applicable to all serotypes and offer a choice of cell line for scale-up. Empty FMDV capsids were visually 
uniform by TEM and antigenically indistinguishable from authentic virus in twin site ELISA. Empty 
capsids are an attractive vaccine candidate for FMDV not only because they do not require high 
biological containment facilities but also because they allow modification to capsid sequences that would 
render infectious virus nonviable. Thus capsid engineering, for example for improved stability, broadened 
immune response (Tobin et al., 2008) or DIVA (Differentiating Infected from Vaccinated Animals) 
compliance may be feasible using the technology described.  
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7. Figure legends 
 
Figure 1. Expression screening of various FMDV P1-2A +/- 3C cassettes. A. Cartoon representation of 
the genetic designs tested. The text near the bottom right represents the amino acid sequence of FMDV 
3C between residues 141-170 with Cys 142 and Cys 163 highlighted.  B. Outcome of screening the 
various A22 Iraq constructs by immunoblotting using a polyvalent A serum. The expected migration 
positions of P1-2A-3C, P1-2A and VP1 are indicated although very little P1-2A-3C is visible. Numbers to 
the left are the migration positions of protein markers and are in kilodaltons.        
Figure 2. Cartoon representation of the vector used for expression of empty FMDV capsids with the 
salient features shown. Unique restriction sites available for the exchange of the capsid polyprotein 
precursor coding region from different serotypes are indicated by red boxes.  B. Translated ORF details of 
the P1-2A polyprotein, the 3C protease and the junctions between them. The frameshift event, which 
begins on the overlapping Phe residue and results in a single polyprotein linking the P1-2A and 3C 
proteins, is indicated by the dotted line. C. Sequence detail of the HIV frameshift (above) and its 
relationship to the translated product (below).   
Figure 3. Time course of expression of FMDV A22 antigen in three insect cell lines. Numbers above the 
track are days post infection in each of the cell lines indicated, with the exception of track 1 which is the 
mock infected control. In panel A, the serum used for immunodetection was a Guinea pig polyvalent A 
serotype (a reagent of the Institute for Animal Health). Panel B is an infection control using a monoclonal 
antibody to the baculovirus surface glycoprotein gp64. Numbers to the left are the migration position of 
protein markers and are in kilodaltons. 
Figure 4. Analysis of empty capsid assembly. A. Sucrose gradient fractionation of FMDV capsid material 
analysed by western blot using A22 serotype antisera with an extract of A22 recombinant virus 
infectedSf9 cells. Numbers at the top are fractions numbers. Numbers to the left are the migration position 
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of protein markers and are in kilodaltons.  B. Peak fractions from the gradient were analysed by TEM. 
The bar is 100nm.  
Figure 5. Antigenic characterisation of recombinant FMDV capsids. Comparison of serotype A22 Iraq 
native antigen and recombinant A22 empty capsids (solid/grey bars) in a twin site ELISA with a panel of 
serum samples. The sera are from animals vaccinated with A Iran05 (1-10), vaccinated and challenged 
with A24 Cruzeiro (11, 12), vaccinated and challenged with A Iran96 (13-18), infected with A22 Iraq 
24/64 (19, 20), infected with A24 Cruzeiro (21-24), infected with A Malaysia 97 (25, 26), infected with A 
Iran99 (27, 28) and vaccinated with A Iran05 (29-38). PI - percentage inhibition. 
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Highlights 
 Efficient expression of FMDV empty capsids in insect cells after moderation of 3C 
protease action 
 Expression cassette productive in multiple insect cells lines 
 Empty capsids visualised by transmission electron microscopy 
 Empty capsids react with wide range of positive sera as well as authentic virus  
 Efficient empty capsid synthesis may allow development as a vaccine.    
*Highlights (for review)
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Revised figure 2
